PPTA Presents at the European Haemophilia Consortium

PPTA presents at the European Haemophilia Consortium Roundtable Event on Health Technology Assessment.

October 9, 2012
Brussels

PPTA presentation:
"Hemophilia and Prophylaxis: A Proposed Whole of Life Approach"
- Albert Farrugia, Vice President, PPTA Global Access

PPTA Welcomes New Executive Director of European Division +

The Plasma Protein Therapeutics Association (PPTA) announced today that Maarten Van Baelen has joined the association as Executive Director, PPTA Europe. Maarten brings to PPTA more than 10 years in the life sciences arena, including as an advocate for access to generic, biosimilar and value-added medicines. He has represented the pharmaceutical sector’s interest in public forums, strategic policy development, and advocacy on key issues with the European Commission, National Competent Authorities, and other stakeholders.
Read More
Registration is now open for the Business Forum! +

Join us on October 17 in San Diego for the 2019 Business Forum! [PPTA Members only]

Click here to register for the 2019 Business Forum. Online registration will close October 10.
Read More
PPTA Statement on Immunoglobulin Access +

Recent media reports have described access issues regarding immunoglobulin (Ig) therapies relied on by people living with primary immunodeficiencies. The Plasma Protein Therapeutics Association (PPTA) is aware of these reports and is working with advocate groups, regulators, and member companies to identify solutions and ensure people can continue treating these serious conditions.
Read More

› ‹

The Source, the international magazine of the plasma protein therapeutics industry, is published quarterly.

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.